Although a lot of studies demonstrates that SLC2A1 mediated the glucose transport in cancer cells, few studies focus on the detail function and the mechanism of SLC2A1 in glioma, and the pathways related with SLC2A1 in cancer progression are also rarely studied. The gene discussed is SLC2A1; the disease is cancer.